ArticleTranslational pediatrics2025
Analysis of risk factors for mortality from carbapenem-resistant
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Validation of an Interpretable Machine Learning Model for Predicting Carbapenem-ResistantInfection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, the spread of carbapenemase in Methods: A total of 42 infants with CRKP bloodstream infection who were admitted or transferred to the PICU of Xinhua Hospital Affiliated to Shanghai Jiaotong University from January 1, 2017, to December 30, 2019, were included in the study, and their demographic characteristics, basic clinical data, invasive procedures, infection indicators, and other relevant data were analyzed. Results: Among the 45 CRE bloodstream infections, CRKP accounted for 93.3% (42/45) and carbapenem-resistant Conclusions: Prevention and control measures should be formulated for the risk factors for mortality from CRKP bloodstream infections in infants, the management process for invasive procedures should be strengthened, and the use of antimicrobial drugs should be controlled to improve prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.